Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disorder without effective medical treatment which is characterized by inflammation and fibrotic structures around the bile ducts. Biliary epithelial cells (cholangiocytes) are the target and potential disease drivers in PSC, yet little is known if cholangiocytes from PSC patients differ from non-PSC controls. To characterize cholangiocytes at early rather than end-stage disease, cholangiocyte organoids (COs) were derived from diseased bile ducts of PSC patients and compared to organoids generated from disease controls. METHODS: Cholangiocytes were obtained during endoscopic retrograde cholangiopancreatography (ERCP) brushing of diseased bile duct areas and expanded as organoids using previously established culture methods. Stable CO lines were analyzed for cell type identity, basic cholangiocyte function, and transcriptomic signature. RESULTS: We demonstrate that cholangiocytes, derived from the damaged area within the bile ducts of PSC patients, can be expanded in culture without displaying functional or genetic disease-related features. We further show that COs from patients who later were diagnosed with dysplasia exhibit higher expression of the cancer-associated genes PGC, FXYD2, MIR4435-2HG, and HES1. CONCLUSIONS: Our results demonstrate that PSC organoids are largely similar to control organoids after culture and highlight the significance of COs as a tool for regenerative medicine approaches as well as their potential for discovering new potential biomarkers for diagnosing cholangiocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, endoscopic retrograde cholangiopancreatography (ERCP)-derived extrahepatic cholangiocyte organoids generated from PSCs and non-PSC patients were shown to be largely similar when cultured in vitro, notably in terms of their BEC marker expression and BEC landmark functions, and they displayed similar responses to inflammatory cytokine stimulation [176].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [176]
In the citing paper
“Finally, PSC is considered a risk factor for intrahepatic cholangiocarcinoma [176].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [176]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 2×
“The ImageJ 1.48 k software [22] was used for image processing.”
MethodInfluentialIntegrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174 · cited 1×
“Seurat [29] clustering, with hyper-parameters optimized on data characteristics using ClustAssess [25], revealed 13 clusters when all CO lines were evaluated together (Fig.”
MethodHafemeister, C., & Satija, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1874-1 · Cited by 4,479 · cited 1×
“15,564 cells passed all the quality control filters, across samples; post-filtering, the expression levels were normalized using SCTransform [24].”
MethodMetsalu, T., & Vilo, J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv468 · Cited by 3,709
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Primary sclerosing cholangitis – a comprehensive review
Karlsen, T. H., Folseraas, T., Thorburn, D., & Vesterhus, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.022 · Cited by 868
Self-citationBoonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725 · cited 1×
“In addition to the progressive nature of the disease leading to liver failure, the ongoing chronic inflammation within the bile ducts puts PSC patients at a high risk of developing cholangiocarcinoma (CCA) that represents a major contributor to PSC-related mortality [4].”
BackgroundCholangiocyte organoids can repair bile ducts after transplantation in the human liver
Sampaziotis, F., Muraro, D., Tysoe, O. C., Sawiak, S., Beach, T. E., Godfrey, E. M., Upponi, S. S., Brevini, T., Wesley, B. T., Garcia-Bernardo, J., et al. (2021) · Science · doi:10.1126/science.aaz6964 · Cited by 394 · cited 3×
“A previous study comparing scRNAseq data from fresh human cholangiocytes to cholangiocyte organoids demonstrated a loss of transcriptional diversity after prolonged cell culture [16].”
BackgroundSelf-citationSampaziotis, F., Justin, A. W., Tysoe, O. C., Sawiak, S., Godfrey, E. M., Upponi, S. S., Gieseck, R. L., de Brito, M. C., Berntsen, N. L., Gómez-Vázquez, M. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4360 · Cited by 296
Self-citationId proteins in cell cycle control and cellular senescence
Zebedee, Z., & Hara, E. (2001) · Oncogene · doi:10.1038/sj.onc.1205092 · Cited by 282
Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241
Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a
Alani, R. M., Young, A. Z., & Shifflett, C. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141235398 · Cited by 227
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells
Dianat, N., Dubois-Pot-Schneider, H., Steichen, C., Desterke, C., Leclerc, P., Raveux, A., Combettes, L., Weber, A., Corlu, A., & Dubart-Kupperschmitt, A. (2014) · Hepatology · doi:10.1002/hep.27165 · Cited by 212
Element-centric clustering comparison unifies overlaps and hierarchy
Gates, A. J., Wood, I. B., Hetrick, W. P., & Ahn, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-44892-y · Cited by 138
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis
Carpino, G., Cardinale, V., Renzi, A., Hov, J. R., Berloco, P. B., Rossi, M., Karlsen, T. H., Alvaro, D., & Gaudio, E. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.018 · Cited by 128
Self-citationTysoe, O., Justin, A. W., Brevini, T., Chen, S. E., Mahbubani, K. T. A., Frank, A. K., Zedira, H., Melum, E., Saeb‐Parsy, K., Markaki, A. E., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0168-0 · Cited by 126
Self-citationPoch, T., Krause, J., Casar, C., Liwinski, T., Glau, L., Kaufmann, M., Ahrenstorf, A. E., Hess, L. U., Ziegler, A. E., Martrus, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.03.016 · Cited by 123
Sampaziotis, F., de Brito, M. C., Geti, I., Bertero, A., Hannan, N. R., & Vallier, L. (2017) · Nature Protocols · doi:10.1038/nprot.2017.011 · Cited by 115
Self-citationRegional Differences in Human Biliary Tissues and Corresponding In Vitro–Derived Organoids
Rimland, C. A., Tilson, S. G., Morell, C. M., Tomaz, R. A., Lu, W., Adams, S. E., Georgakopoulos, N., Otaizo‐Carrasquero, F., Myers, T. G., Ferdinand, J. R., et al. (2021) · Hepatology · doi:10.1002/hep.31252 · Cited by 110 · cited 1×
“…note, future studies should also address potential functional differences between intra-and extrahepatic cholangiocytes in PSC given the known differences between cholangiocytes in these two compartments [34], as our current study comprises the study of extrahepatic cholangiocyte organoids solely.”
BackgroundSelf-citationTabibian, J. H., Trussoni, C. E., O'Hara, S. P., Splinter, P. L., Heimbach, J. K., & LaRusso, N. F. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.94 · Cited by 104
Soroka, C. J., Assis, D. N., Alrabadi, L. S., Roberts, S., Cusack, L., Jaffe, A. B., & Boyer, J. L. (2019) · Hepatology · doi:10.1002/hep.30470 · Cited by 97
Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis
Chung, B. K., Øgaard, J., Reims, H. M., Karlsen, T. H., & Melum, E. (2022) · Hepatology Communications · doi:10.1002/hep4.2001 · Cited by 85 · cited 1×
“Spatial transcriptomics and sequencing have previously been described for the dataset used [28].”
MethodSelf-citationLiaskou, E., Henriksen, E. K. K., Holm, K., Kaveh, F., Hamm, D., Fear, J., Viken, M. K., Hov, J. R., Melum, E., Robins, H., et al. (2016) · Hepatology · doi:10.1002/hep.28116 · Cited by 83
Self-citationOrganoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
Sato, K., Zhang, W., Safarikia, S., Isidan, A., Chen, A. M., Li, P., Francis, H., Kennedy, L., Baiocchi, L., Alvaro, D., et al. (2021) · Hepatology · doi:10.1002/hep.31653 · Cited by 70
Functional Role of Cellular Senescence in Biliary Injury
Meng, L., Quezada, M., Levine, P., Han, Y., McDaniel, K., Zhou, T., Lin, E., Glaser, S., Meng, F., Francis, H., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.027 · Cited by 68
Will we ever model PSC? – “It's hard to be a PSC model!”
Pollheimer, M. J., Trauner, M., & Fickert, P. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.04.014 · Cited by 66 · cited 1×
“Clarification of cholangio-cyte biology and the pathophysiology in PSC has been hampered by inadequate disease models and challenges in culturing and expanding cholangiocytes isolated from bile ducts of PSC patients [13, 14].”
BackgroundThe Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis
Guicciardi, M. E., Trussoni, C. E., LaRusso, N. F., & Gores, G. J. (2020) · Hepatology · doi:10.1002/hep.31067 · Cited by 62
Gates, A. J., & Ahn, Y. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.2598681 · Cited by 61
MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
Zhong, C., Xie, Z., Zeng, L., Yuan, C., & Duan, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.855078 · Cited by 60
Chung, B. K., Guevel, B. T., Reynolds, G. M., Gupta Udatha, D. B. R. K., Henriksen, E. K. K., Stamataki, Z., Hirschfield, G. M., Karlsen, T. H., & Liaskou, E. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.10.003 · Cited by 57
Self-citationLoarca, L., De Assuncao, T. M., Jalan-Sakrikar, N., Bronk, S., Krishnan, A., Huang, B., Morton, L., Trussoni, C., Bonilla, L. M., Krueger, E., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.63 · Cited by 53
Tabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52 · cited 1×
“Biliary epithelial cells (cholangiocytes) are a heterogeneous group of biliary cells lining the bile ducts which modify the content of bile as it is transported along the biliary tract [8].”
BackgroundThe panoramic picture of pepsinogen gene family with pan‐cancer
Shen, S., Li, H., Liu, J., Sun, L. L., & Yuan, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.3489 · Cited by 47
Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets
Sato, K., Glaser, S. S., Kennedy, L. L., Liangpunsakul, S., Meng, F., Francis, H., & Alpini, G. D. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1608950 · Cited by 27
Jalan‐Sakrikar, N., de Assuncao, T. M., Navarro‐Corcuera, A., Hamdan, F. H., Loarca, L., Kirkeby, L. A., Resch, Z. T., O’Hara, S. P., Juran, B. D., Lazaridis, K. N., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1809 · Cited by 26
Matsumori, T., Kodama, Y., Takai, A., Shiokawa, M., Nishikawa, Y., Matsumoto, T., Takeda, H., Marui, S., Okada, H., Hirano, T., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1161 · Cited by 20
Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art
Lang, S. A., Bednarsch, J., Joechle, K., Amygdalos, I., Czigány, Z., Heij, L. R., Ulmer, T. F., & Neumann, U. P. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1912591 · Cited by 19
Zhang, Z., Tang, Y., Li, L., Yang, W., Xu, Y., Zhou, J., Ma, K., Zhang, K., Zhuang, H., Gong, Y., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/4946197 · Cited by 12
Matsumori, T. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k23369 · Cited by 3
Research works printed but not linked: 1
- Arash S, Munteanu A, Mohorianu I. ClustAssess: tools for assessing the robustness of single-cell clustering. bioRxiv. 2022; 2022–01.
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Molecular Basis of Na, K–ATPase Regulation of Diseases: Hormone and FXYD2 Interactions
Cordeiro, B. M., Fontes, C. F. L., & Meyer‐Fernandes, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413398 · Cited by 22
Advances in Biliary Disease Organoid Research: From Model Construction to Clinical Applications
Peng, B., Huang, M., Zhang, J., & Xiang, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501776 · Cited by 8
Applications of 3D models in cholangiocarcinoma
Montagner, A., Lemberger-Viehmann, L., Reitberger, N., Schmidt, M., Scheruebl, J., Pion, E., Wagner, B. J., Pilarsky, C. P., Grützmann, R., Aung, T., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1598552 · Cited by 7
Jalan‐Sakrikar, N., Anwar, A. A., Ali, A., Nasser‐Ghodsi, N., Felzen, A., Huebert, R. C., LaRusso, N. F., & O’Hara, S. P. (2026) · Physiological Reviews · doi:10.1152/physrev.00022.2025 · Cited by 5
Metadata
- Authors
- Frank, A. K., Chung, B. K., De Novales, M. L. L., Engesæter, L. K., Hoyle, H. W., Øgaard, J., Heslop, J., Karlsen, T. H., Tysoe, O., Brevini, T., Tchorz, J. S., Vallier, L., Mohorianu, I., Sampaziotis, F., & Melum, E.
- Affiliations
- Oslo University Hospital (NO)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Novartis (Switzerland) (CH)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Corresponding author
- Melum, Espen
- ORCID
- Venue
- Digestive Diseases and Sciences
- Published
- 2024-08-19
- Volume
- 69
- Issue
- 10
- Pages
- 3810-3823
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC11489200
- OpenAlex
- W4401691134
- Cited by
- 14
- References
- 41
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 1
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- Digestive Diseases and Sciences (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- Funders
- Scientia Fellowship European Union`s Horizon 2020 research and innovation program (No 801133)
- Norwegian PSC Research Center
- European Research Council (New-Chol)
- Norwegian Research council (315399)
- University of Oslo
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- primary sclerosing cholangitis, cholangiocytes, cholangiocyte organoids, bile ducts, single-cell transcriptomics, dysplasia, Hes1, PGC, FXYD2, MIR4435-2HG, regenerative medicine, endoscopic retrograde cholangiopancreatography
- MeSH terms
- Bile Ducts, Epithelial Cells, Female, Humans, Male, Organoids, Cholangitis, Sclerosing, Gene Expression Profiling, Single-Cell Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.